Stem cell transplants in utero offers Tx for metabolic disorders that often end pregnancy
(PHYSorg.com Medicine & Health)

Administering stem cell or enzyme therapy in utero may be a path to alleviating some congenital diseases that often result in losing a pregnancy, according to a new study in mice by UC San Francisco researchers, who showed that stem cells can enter the fetal brain during prenatal development and make up for cells that fail to make an essential protein.